FT709 is a potent and selective USP9X inhibitor, an IC 50 of 82 nM. USP9X has been linked with centrosome function, chromosome alignment during mitosis , EGF receptor degradation, chemo-sensitization, and circadian rhythms.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Deubiquitinase | Products > Signaling Pathways > Mitosis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.